Global Respiratory Distress Syndrome Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • receipt Report ID : 137782
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.

According to our latest study, the global Respiratory Distress Syndrome market size was valued at USD 388.6 million in 2022 and is forecast to a readjusted size of USD 556.5 million by 2029 with a CAGR of 5.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.

This report is a detailed and comprehensive analysis for global Respiratory Distress Syndrome market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Respiratory Distress Syndrome market size and forecasts, in consumption value ($ Million), 2018-2029

Global Respiratory Distress Syndrome market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Respiratory Distress Syndrome market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Respiratory Distress Syndrome market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Respiratory Distress Syndrome

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Respiratory Distress Syndrome market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie and Yuhan Corporation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Respiratory Distress Syndrome market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Poractant Alfa

Beractant

Calfactant

Others

Market segment by Application

Very Preterm Infants

Moderate to Late Preterm Infants

Others

Market segment by players, this report covers

Chiesi Farmaceutici

CR-Double Crane

ONY Biotech

AbbVie

Yuhan Corporation

JW Pharmaceuticals

Noargen

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Argentina and Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Respiratory Distress Syndrome product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Respiratory Distress Syndrome, with revenue, gross margin and global market share of Respiratory Distress Syndrome from 2018 to 2023.

Chapter 3, the Respiratory Distress Syndrome competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Respiratory Distress Syndrome market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Respiratory Distress Syndrome.

Chapter 13, to describe Respiratory Distress Syndrome research findings and conclusion.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Respiratory Distress Syndrome

1.2 Market Estimation Caveats and Base Year

1.3 Classification of Respiratory Distress Syndrome by Type

1.3.1 Overview: Global Respiratory Distress Syndrome Market Size by Type: 2018 Versus 2022 Versus 2029

1.3.2 Global Respiratory Distress Syndrome Consumption Value Market Share by Type in 2022

1.3.3 Poractant Alfa

1.3.4 Beractant

1.3.5 Calfactant

1.3.6 Others

1.4 Global Respiratory Distress Syndrome Market by Application

1.4.1 Overview: Global Respiratory Distress Syndrome Market Size by Application: 2018 Versus 2022 Versus 2029

1.4.2 Very Preterm Infants

1.4.3 Moderate to Late Preterm Infants

1.4.4 Others

1.5 Global Respiratory Distress Syndrome Market Size & Forecast

1.6 Global Respiratory Distress Syndrome Market Size and Forecast by Region

1.6.1 Global Respiratory Distress Syndrome Market Size by Region: 2018 VS 2022 VS 2029

1.6.2 Global Respiratory Distress Syndrome Market Size by Region, (2018-2029)

1.6.3 North America Respiratory Distress Syndrome Market Size and Prospect (2018-2029)

1.6.4 Europe Respiratory Distress Syndrome Market Size and Prospect (2018-2029)

1.6.5 Asia-Pacific Respiratory Distress Syndrome Market Size and Prospect (2018-2029)

1.6.6 South America Respiratory Distress Syndrome Market Size and Prospect (2018-2029)

1.6.7 Middle East and Africa Respiratory Distress Syndrome Market Size and Prospect (2018-2029)

2 Company Profiles

2.1 Chiesi Farmaceutici

2.1.1 Chiesi Farmaceutici Details

2.1.2 Chiesi Farmaceutici Major Business

2.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Product and Solutions

2.1.4 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 Chiesi Farmaceutici Recent Developments and Future Plans

2.2 CR-Double Crane

2.2.1 CR-Double Crane Details

2.2.2 CR-Double Crane Major Business

2.2.3 CR-Double Crane Respiratory Distress Syndrome Product and Solutions

2.2.4 CR-Double Crane Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 CR-Double Crane Recent Developments and Future Plans

2.3 ONY Biotech

2.3.1 ONY Biotech Details

2.3.2 ONY Biotech Major Business

2.3.3 ONY Biotech Respiratory Distress Syndrome Product and Solutions

2.3.4 ONY Biotech Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 ONY Biotech Recent Developments and Future Plans

2.4 AbbVie

2.4.1 AbbVie Details

2.4.2 AbbVie Major Business

2.4.3 AbbVie Respiratory Distress Syndrome Product and Solutions

2.4.4 AbbVie Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 AbbVie Recent Developments and Future Plans

2.5 Yuhan Corporation

2.5.1 Yuhan Corporation Details

2.5.2 Yuhan Corporation Major Business

2.5.3 Yuhan Corporation Respiratory Distress Syndrome Product and Solutions

2.5.4 Yuhan Corporation Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 Yuhan Corporation Recent Developments and Future Plans

2.6 JW Pharmaceuticals

2.6.1 JW Pharmaceuticals Details

2.6.2 JW Pharmaceuticals Major Business

2.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Product and Solutions

2.6.4 JW Pharmaceuticals Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2023)

2.6.5 JW Pharmaceuticals Recent Developments and Future Plans

2.7 Noargen

2.7.1 Noargen Details

2.7.2 Noargen Major Business

2.7.3 Noargen Respiratory Distress Syndrome Product and Solutions

2.7.4 Noargen Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2018-2023)

2.7.5 Noargen Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Respiratory Distress Syndrome Revenue and Share by Players (2018-2023)

3.2 Market Share Analysis (2022)

3.2.1 Market Share of Respiratory Distress Syndrome by Company Revenue

3.2.2 Top 3 Respiratory Distress Syndrome Players Market Share in 2022

3.2.3 Top 6 Respiratory Distress Syndrome Players Market Share in 2022

3.3 Respiratory Distress Syndrome Market: Overall Company Footprint Analysis

3.3.1 Respiratory Distress Syndrome Market: Region Footprint

3.3.2 Respiratory Distress Syndrome Market: Company Product Type Footprint

3.3.3 Respiratory Distress Syndrome Market: Company Product Application Footprint

3.4 New Market Entrants and Barriers to Market Entry

3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Respiratory Distress Syndrome Consumption Value and Market Share by Type (2018-2023)

4.2 Global Respiratory Distress Syndrome Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

5.1 Global Respiratory Distress Syndrome Consumption Value Market Share by Application (2018-2023)

5.2 Global Respiratory Distress Syndrome Market Forecast by Application (2024-2029)

6 North America

6.1 North America Respiratory Distress Syndrome Consumption Value by Type (2018-2029)

6.2 North America Respiratory Distress Syndrome Consumption Value by Application (2018-2029)

6.3 North America Respiratory Distress Syndrome Market Size by Country

6.3.1 North America Respiratory Distress Syndrome Consumption Value by Country (2018-2029)

6.3.2 United States Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

6.3.3 Canada Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

6.3.4 Mexico Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

7 Europe

7.1 Europe Respiratory Distress Syndrome Consumption Value by Type (2018-2029)

7.2 Europe Respiratory Distress Syndrome Consumption Value by Application (2018-2029)

7.3 Europe Respiratory Distress Syndrome Market Size by Country

7.3.1 Europe Respiratory Distress Syndrome Consumption Value by Country (2018-2029)

7.3.2 Germany Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

7.3.3 France Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

7.3.4 United Kingdom Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

7.3.5 Russia Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

7.3.6 Italy Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

8 Asia-Pacific

8.1 Asia-Pacific Respiratory Distress Syndrome Consumption Value by Type (2018-2029)

8.2 Asia-Pacific Respiratory Distress Syndrome Consumption Value by Application (2018-2029)

8.3 Asia-Pacific Respiratory Distress Syndrome Market Size by Region

8.3.1 Asia-Pacific Respiratory Distress Syndrome Consumption Value by Region (2018-2029)

8.3.2 China Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

8.3.3 Japan Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

8.3.4 South Korea Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

8.3.5 India Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

8.3.6 Southeast Asia Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

8.3.7 Australia Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

9 South America

9.1 South America Respiratory Distress Syndrome Consumption Value by Type (2018-2029)

9.2 South America Respiratory Distress Syndrome Consumption Value by Application (2018-2029)

9.3 South America Respiratory Distress Syndrome Market Size by Country

9.3.1 South America Respiratory Distress Syndrome Consumption Value by Country (2018-2029)

9.3.2 Brazil Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

9.3.3 Argentina Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

10 Middle East & Africa

10.1 Middle East & Africa Respiratory Distress Syndrome Consumption Value by Type (2018-2029)

10.2 Middle East & Africa Respiratory Distress Syndrome Consumption Value by Application (2018-2029)

10.3 Middle East & Africa Respiratory Distress Syndrome Market Size by Country

10.3.1 Middle East & Africa Respiratory Distress Syndrome Consumption Value by Country (2018-2029)

10.3.2 Turkey Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

10.3.3 Saudi Arabia Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

10.3.4 UAE Respiratory Distress Syndrome Market Size and Forecast (2018-2029)

11 Market Dynamics

11.1 Respiratory Distress Syndrome Market Drivers

11.2 Respiratory Distress Syndrome Market Restraints

11.3 Respiratory Distress Syndrome Trends Analysis

11.4 Porters Five Forces Analysis

11.4.1 Threat of New Entrants

11.4.2 Bargaining Power of Suppliers

11.4.3 Bargaining Power of Buyers

11.4.4 Threat of Substitutes

11.4.5 Competitive Rivalry

11.5 Influence of COVID-19 and Russia-Ukraine War

11.5.1 Influence of COVID-19

11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

12.1 Respiratory Distress Syndrome Industry Chain

12.2 Respiratory Distress Syndrome Upstream Analysis

12.3 Respiratory Distress Syndrome Midstream Analysis

12.4 Respiratory Distress Syndrome Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Respiratory Distress Syndrome Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global Respiratory Distress Syndrome Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. Global Respiratory Distress Syndrome Consumption Value by Region (2018-2023) & (USD Million)

Table 4. Global Respiratory Distress Syndrome Consumption Value by Region (2024-2029) & (USD Million)

Table 5. Chiesi Farmaceutici Company Information, Head Office, and Major Competitors

Table 6. Chiesi Farmaceutici Major Business

Table 7. Chiesi Farmaceutici Respiratory Distress Syndrome Product and Solutions

Table 8. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 9. Chiesi Farmaceutici Recent Developments and Future Plans

Table 10. CR-Double Crane Company Information, Head Office, and Major Competitors

Table 11. CR-Double Crane Major Business

Table 12. CR-Double Crane Respiratory Distress Syndrome Product and Solutions

Table 13. CR-Double Crane Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 14. CR-Double Crane Recent Developments and Future Plans

Table 15. ONY Biotech Company Information, Head Office, and Major Competitors

Table 16. ONY Biotech Major Business

Table 17. ONY Biotech Respiratory Distress Syndrome Product and Solutions

Table 18. ONY Biotech Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 19. ONY Biotech Recent Developments and Future Plans

Table 20. AbbVie Company Information, Head Office, and Major Competitors

Table 21. AbbVie Major Business

Table 22. AbbVie Respiratory Distress Syndrome Product and Solutions

Table 23. AbbVie Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 24. AbbVie Recent Developments and Future Plans

Table 25. Yuhan Corporation Company Information, Head Office, and Major Competitors

Table 26. Yuhan Corporation Major Business

Table 27. Yuhan Corporation Respiratory Distress Syndrome Product and Solutions

Table 28. Yuhan Corporation Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 29. Yuhan Corporation Recent Developments and Future Plans

Table 30. JW Pharmaceuticals Company Information, Head Office, and Major Competitors

Table 31. JW Pharmaceuticals Major Business

Table 32. JW Pharmaceuticals Respiratory Distress Syndrome Product and Solutions

Table 33. JW Pharmaceuticals Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 34. JW Pharmaceuticals Recent Developments and Future Plans

Table 35. Noargen Company Information, Head Office, and Major Competitors

Table 36. Noargen Major Business

Table 37. Noargen Respiratory Distress Syndrome Product and Solutions

Table 38. Noargen Respiratory Distress Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 39. Noargen Recent Developments and Future Plans

Table 40. Global Respiratory Distress Syndrome Revenue (USD Million) by Players (2018-2023)

Table 41. Global Respiratory Distress Syndrome Revenue Share by Players (2018-2023)

Table 42. Breakdown of Respiratory Distress Syndrome by Company Type (Tier 1, Tier 2, and Tier 3)

Table 43. Market Position of Players in Respiratory Distress Syndrome, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022

Table 44. Head Office of Key Respiratory Distress Syndrome Players

Table 45. Respiratory Distress Syndrome Market: Company Product Type Footprint

Table 46. Respiratory Distress Syndrome Market: Company Product Application Footprint

Table 47. Respiratory Distress Syndrome New Market Entrants and Barriers to Market Entry

Table 48. Respiratory Distress Syndrome Mergers, Acquisition, Agreements, and Collaborations

Table 49. Global Respiratory Distress Syndrome Consumption Value (USD Million) by Type (2018-2023)

Table 50. Global Respiratory Distress Syndrome Consumption Value Share by Type (2018-2023)

Table 51. Global Respiratory Distress Syndrome Consumption Value Forecast by Type (2024-2029)

Table 52. Global Respiratory Distress Syndrome Consumption Value by Application (2018-2023)

Table 53. Global Respiratory Distress Syndrome Consumption Value Forecast by Application (2024-2029)

Table 54. North America Respiratory Distress Syndrome Consumption Value by Type (2018-2023) & (USD Million)

Table 55. North America Respiratory Distress Syndrome Consumption Value by Type (2024-2029) & (USD Million)

Table 56. North America Respiratory Distress Syndrome Consumption Value by Application (2018-2023) & (USD Million)

Table 57. North America Respiratory Distress Syndrome Consumption Value by Application (2024-2029) & (USD Million)

Table 58. North America Respiratory Distress Syndrome Consumption Value by Country (2018-2023) & (USD Million)

Table 59. North America Respiratory Distress Syndrome Consumption Value by Country (2024-2029) & (USD Million)

Table 60. Europe Respiratory Distress Syndrome Consumption Value by Type (2018-2023) & (USD Million)

Table 61. Europe Respiratory Distress Syndrome Consumption Value by Type (2024-2029) & (USD Million)

Table 62. Europe Respiratory Distress Syndrome Consumption Value by Application (2018-2023) & (USD Million)

Table 63. Europe Respiratory Distress Syndrome Consumption Value by Application (2024-2029) & (USD Million)

Table 64. Europe Respiratory Distress Syndrome Consumption Value by Country (2018-2023) & (USD Million)

Table 65. Europe Respiratory Distress Syndrome Consumption Value by Country (2024-2029) & (USD Million)

Table 66. Asia-Pacific Respiratory Distress Syndrome Consumption Value by Type (2018-2023) & (USD Million)

Table 67. Asia-Pacific Respiratory Distress Syndrome Consumption Value by Type (2024-2029) & (USD Million)

Table 68. Asia-Pacific Respiratory Distress Syndrome Consumption Value by Application (2018-2023) & (USD Million)

Table 69. Asia-Pacific Respiratory Distress Syndrome Consumption Value by Application (2024-2029) & (USD Million)

Table 70. Asia-Pacific Respiratory Distress Syndrome Consumption Value by Region (2018-2023) & (USD Million)

Table 71. Asia-Pacific Respiratory Distress Syndrome Consumption Value by Region (2024-2029) & (USD Million)

Table 72. South America Respiratory Distress Syndrome Consumption Value by Type (2018-2023) & (USD Million)

Table 73. South America Respiratory Distress Syndrome Consumption Value by Type (2024-2029) & (USD Million)

Table 74. South America Respiratory Distress Syndrome Consumption Value by Application (2018-2023) & (USD Million)

Table 75. South America Respiratory Distress Syndrome Consumption Value by Application (2024-2029) & (USD Million)

Table 76. South America Respiratory Distress Syndrome Consumption Value by Country (2018-2023) & (USD Million)

Table 77. South America Respiratory Distress Syndrome Consumption Value by Country (2024-2029) & (USD Million)

Table 78. Middle East & Africa Respiratory Distress Syndrome Consumption Value by Type (2018-2023) & (USD Million)

Table 79. Middle East & Africa Respiratory Distress Syndrome Consumption Value by Type (2024-2029) & (USD Million)

Table 80. Middle East & Africa Respiratory Distress Syndrome Consumption Value by Application (2018-2023) & (USD Million)

Table 81. Middle East & Africa Respiratory Distress Syndrome Consumption Value by Application (2024-2029) & (USD Million)

Table 82. Middle East & Africa Respiratory Distress Syndrome Consumption Value by Country (2018-2023) & (USD Million)

Table 83. Middle East & Africa Respiratory Distress Syndrome Consumption Value by Country (2024-2029) & (USD Million)

Table 84. Respiratory Distress Syndrome Raw Material

Table 85. Key Suppliers of Respiratory Distress Syndrome Raw Materials

List of Figures

Figure 1. Respiratory Distress Syndrome Picture

Figure 2. Global Respiratory Distress Syndrome Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global Respiratory Distress Syndrome Consumption Value Market Share by Type in 2022

Figure 4. Poractant Alfa

Figure 5. Beractant

Figure 6. Calfactant

Figure 7. Others

Figure 8. Global Respiratory Distress Syndrome Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 9. Respiratory Distress Syndrome Consumption Value Market Share by Application in 2022

Figure 10. Very Preterm Infants Picture

Figure 11. Moderate to Late Preterm Infants Picture

Figure 12. Others Picture

Figure 13. Global Respiratory Distress Syndrome Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 14. Global Respiratory Distress Syndrome Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 15. Global Market Respiratory Distress Syndrome Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)

Figure 16. Global Respiratory Distress Syndrome Consumption Value Market Share by Region (2018-2029)

Figure 17. Global Respiratory Distress Syndrome Consumption Value Market Share by Region in 2022

Figure 18. North America Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 19. Europe Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 20. Asia-Pacific Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 21. South America Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 22. Middle East and Africa Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 23. Global Respiratory Distress Syndrome Revenue Share by Players in 2022

Figure 24. Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022

Figure 25. Global Top 3 Players Respiratory Distress Syndrome Market Share in 2022

Figure 26. Global Top 6 Players Respiratory Distress Syndrome Market Share in 2022

Figure 27. Global Respiratory Distress Syndrome Consumption Value Share by Type (2018-2023)

Figure 28. Global Respiratory Distress Syndrome Market Share Forecast by Type (2024-2029)

Figure 29. Global Respiratory Distress Syndrome Consumption Value Share by Application (2018-2023)

Figure 30. Global Respiratory Distress Syndrome Market Share Forecast by Application (2024-2029)

Figure 31. North America Respiratory Distress Syndrome Consumption Value Market Share by Type (2018-2029)

Figure 32. North America Respiratory Distress Syndrome Consumption Value Market Share by Application (2018-2029)

Figure 33. North America Respiratory Distress Syndrome Consumption Value Market Share by Country (2018-2029)

Figure 34. United States Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 35. Canada Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 36. Mexico Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 37. Europe Respiratory Distress Syndrome Consumption Value Market Share by Type (2018-2029)

Figure 38. Europe Respiratory Distress Syndrome Consumption Value Market Share by Application (2018-2029)

Figure 39. Europe Respiratory Distress Syndrome Consumption Value Market Share by Country (2018-2029)

Figure 40. Germany Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 41. France Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 42. United Kingdom Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 43. Russia Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 44. Italy Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 45. Asia-Pacific Respiratory Distress Syndrome Consumption Value Market Share by Type (2018-2029)

Figure 46. Asia-Pacific Respiratory Distress Syndrome Consumption Value Market Share by Application (2018-2029)

Figure 47. Asia-Pacific Respiratory Distress Syndrome Consumption Value Market Share by Region (2018-2029)

Figure 48. China Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 49. Japan Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 50. South Korea Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 51. India Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 52. Southeast Asia Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 53. Australia Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 54. South America Respiratory Distress Syndrome Consumption Value Market Share by Type (2018-2029)

Figure 55. South America Respiratory Distress Syndrome Consumption Value Market Share by Application (2018-2029)

Figure 56. South America Respiratory Distress Syndrome Consumption Value Market Share by Country (2018-2029)

Figure 57. Brazil Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 58. Argentina Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 59. Middle East and Africa Respiratory Distress Syndrome Consumption Value Market Share by Type (2018-2029)

Figure 60. Middle East and Africa Respiratory Distress Syndrome Consumption Value Market Share by Application (2018-2029)

Figure 61. Middle East and Africa Respiratory Distress Syndrome Consumption Value Market Share by Country (2018-2029)

Figure 62. Turkey Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 63. Saudi Arabia Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 64. UAE Respiratory Distress Syndrome Consumption Value (2018-2029) & (USD Million)

Figure 65. Respiratory Distress Syndrome Market Drivers

Figure 66. Respiratory Distress Syndrome Market Restraints

Figure 67. Respiratory Distress Syndrome Market Trends

Figure 68. Porters Five Forces Analysis

Figure 69. Manufacturing Cost Structure Analysis of Respiratory Distress Syndrome in 2022

Figure 70. Manufacturing Process Analysis of Respiratory Distress Syndrome

Figure 71. Respiratory Distress Syndrome Industrial Chain

Figure 72. Methodology

Figure 73. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz